Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo

Gut

Volumn 57, Issue 3, 2008, Pages 352-364

  De Minicis, S ^a   Candelaresi, C ^a   Marzioni, M ^a   Saccomano, S ^a   Roskams, T ^b   Casini, A ^c   Risaliti, A ^a   Salzano, R ^c   Cautero, N ^a   Di Francesco, F ^a   Benedetti, A ^a   Svegliati Baroni, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; DIMETHYLNITROSAMINE; METENKEPHALIN; MITOGEN ACTIVATED PROTEIN KINASE; NALOXONE; OPIATE; OPIATE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL STIMULATION; CHRONIC LIVER DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROGENESIS; HEPATIC STELLATE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER NECROSIS; MALE; MORPHOMETRICS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STELLATE CELL;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; COLLAGEN TYPE I; DIMETHYLNITROSAMINE; DISEASE PROGRESSION; ENKEPHALIN, METHIONINE; HEPATOCYTES; HUMANS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER DISEASES; MALE; OPIOID PEPTIDES; PARACRINE COMMUNICATION; RATS; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 39649112634     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.120303     Document Type: Article

References (45)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18.
2. Svegliati-Baroni G, D'Ambrosio L, Curto P, et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996;23:1189- 99.
3. MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986:221-32.
4. Hines JE, Johnson SJ, Burt AD. In vivo response of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol 1993;142:511-8.
5. Svegliati-Baroni G, Pastorelli A, Manzin A, et al. Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C. Liver 1999;19:212-9.
6. Svegliati-Baroni G, D'Ambrosio L, Ferretti G, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998;27:720-6.
7. Tavill AS, Sharma BK, Bacon BR. Iron and the liver: genetic hemochromatosis and other hepatic iron overload disorders. Ann N Y Acad Sci 1985;526.
8. Roskams T, van den Oord JJ, De Vos R, et al. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol 1990;137:1019-25.
9. Cassiman D, Denef C, Desmet VJ, et al. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 2001;33:148-58.
10. Cassiman D, Libbrecht L, Desmet V, et al. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002;36:200-9.
11. Oben JA, Yang S, Lin H, et al. Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells. Biochem Biophys Res Commun 2003;302:685-90.
12. Oben JA, Roskams T, Yang S, et al. Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem Biophys Res Commun 2003;308:284-92.
13. Oben JA, Roskams T, Yang S, et al. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 2004;53:438-45.
14. Oakley F, Trim N, Constandinou CM, et al. Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol 2003;163:1849-58.
15. Glasel JA. The effects of morphine on cell proliferation. Prog Drug Res 2000;55:33-80.
16. Wollemann M, Benyhe S. Non-opioid actions of opioid peptides. Life Sci 2004;75:257-70.
17. Bergasa NV, Sabol SL, Young WS 3rd, et al. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 1995;268:G346-54.
18. Bergasa NV, Vergalla J, Swain MG, et al. Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis. Liver 1996;16:298-302.
19. Bergasa NV, Liau S, Homel P, et al. Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis. Liver 2002;22:107-13.
20. Marzioni M, Alpini G, Saccomanno S, et al. Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis. Gastroenterology 2006;130:1831-47.
21. Swain MG, Rothman RB, Xu H, et al. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 1992;103:630-5.
22. Ebrahimkhani MR, Kiani S, Oakley F, et al. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 2006;16:16.
23. Thornton JR, Losowsky MS. Plasma leucine enkephalin is increased in liver disease. Gut 1989;30:1392-5.
24. Thornton JR, Losowsky MS. Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine. J Hepatol 1989;8:53-9.
25. Svegliati-Baroni G, Ridolfi F, Di Sario A, et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 1999;29:1743-51.
26. Zagon IS, Smith JP, McLaughlin PJ. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int J Oncol 1999;14:577-84.
27. Svegliati-Baroni G, Inagaki Y, Rincon-Sanchez AR, et al. Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. Hepatology 2005;42:343-52.
28. Benedetti A, Di Sario A, Casini A, et al. Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. Gastroenterology 2001;120:545-56.
29. Cao Z, Liu L, Van Winkle DM. Met5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K. Am J Physiol Heart Circ Physiol 2005;288:H1955-64.
30. Hirning LD, Mosberg HI, Hurst R, et al. Studies in vitro with ICI 174,864, [D-Pen2, D-Pen5]-enkephalin (DPDPE) and [D-Ala2, NMePhe4, Gly-ol]-enkephalin (DAGO). Neuropeptides 1985;5:383-6.
31. Kramer TH, Shook JE, Kazmierski W, et al. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. J Pharmacol Exp Ther 1989;249:544-51.
32. Portoghese PS, Nagase H, Lipkowski AW, et al. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity. J Med Chem 1988;31:836-41.
33. Marzioni M, Glaser S, Francis H, et al. Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 2005;128:121-37.
34. Liu BH, Mo P, Zhang SB. Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon. World J Gastroenterol 2004;10:1672-4.
35. Svegliati-Baroni G, Ridolfi F, Hannivoort R, et al. Bile acids induce hepatic stellate cell proliferation via activation of the EGF-receptor. Gastroenterology 2005;128:1042-55.
36. Gallate JE, Mallet PE, McGregor IS. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology (Berl) 2004;173:210-6.
37. Svegliati-Baroni G, Ridolfi F, Caradonna Z, et al. Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis. J Hepatol 2003;39:528-37.
38. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
39. Yang L, Chan CC, Kwon OS, et al. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2006;291:G902-11.
40. Svegliati-Baroni G, Saccomanno S, van Goor H, et al. Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver 2001;21:1-12.
41. Trigueiro de Araujo MS, Gerard F, Chossegros P, et al. Cellular and matrix changes in drug abuser liver sinusoids: a semiquantitative and morphometric ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1993;422:145-52.
42. Tanowitz M, von Zastrow M. A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors. J Biol Chem 2003;278:45978-86.
43. Bergasa NV, Rothman RB, Vergalla J, et al. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 1992;15:220-4.
44. Kiani S, Ebrahimkhani MR, Shariftabrizi A, et al. Opioid system blockade decreases collagenase activity and improves liver injury in a rat model of cholestasis. J Gastroenterol Hepatol 2007;22:406-13.
45. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liver Dis 1990;10:56-65.